Changes to This $100 Billion Federal Drug Program Could Make Banks the Hidden Beneficiaries
A proposed federal drug-discount overhaul could quietly funnel billions in new borrowing demand toward the banks already holding hospital credit lines, and the lenders best positioned to profit may surprise you. Hospitals serving large numbers of low-income patients accounted for…